Skip to main content
PLOS Neglected Tropical Diseases logoLink to PLOS Neglected Tropical Diseases
. 2024 Jul 22;18(7):e0012328. doi: 10.1371/journal.pntd.0012328

Zoonotic Sporotrichosis outbreak: Emerging public health threat in the Amazon State, Brazil

Viviany Araujo Mesquita 1, Sinesio Talhari 1,2, André Luiz Leturiondo 1,2, Guilherme Caldas de Souza 1, Euzenio Moreira de Brito 1, Suanni Lemos de Andrade 1,3, Débora Cristina de Lima Fernandes 2, Maria Zeli Moreira Frota 4, Rossilene Conceição da Silva Cruz 1,2, Juliana de Andrade Rebouças Guimarães 1,5, Helio Amante Miot 6, Carolina Talhari 1,7,*, Valderiza Lourenço Pedrosa 1,2
Editor: Joshua Nosanchuk8
PMCID: PMC11293696  PMID: 39038043

Abstract

Background

Sporotrichosis is the most common subcutaneous mycosis caused by Sporothrix spp. Traditionally, it is transmitted through injuries involving plant debris. However, over the past few decades, there has been an epidemic increase in human cases resulting from contact with infected animals, particularly cats, in various regions of Brazil. In this report, we report a notable increase in both human and animal cases within the Brazilian Amazon state.

Methodology/Principal findings

An ecological study was conducted by analyzing official records of human and animal sporotrichosis diagnosed in the state of Amazon from 2020 to 2023. Data including patient demographics, clinical manifestations, mycological examination results, and species identification through PCR confirmation were evaluated. During this period, a total of 950 human cases and 2,823 animal cases of sporotrichosis were reported at an exponential rate, since no human cases were registered in 2020. The spatial and temporal dispersion of human sporotrichosis followed that of animal cases, moving from downtown areas to the periphery. Contact with infected animals was reported in 77.7% of cases, with cats being the most commonly implicated (73.5%). Only 66.7% of individuals underwent mycological examination. Among the positive cultures for Sporothrix spp., 65.4% were identified as S. brasiliensis. All patients were treated with systemic antifungals.

Conclusions/Significance

This study highlights a rising incidence of sporotrichosis among animals and humans in the Brazilian Amazon region over the past four years, with S. brasiliensis being the predominant agent. Collaborative efforts involving healthcare professionals, veterinarians, and public health authorities are crucial to implement effective control measures, educate populations at risk, and promote responsible guidance for pet guardians. These measures are essential to mitigate the burden of epidemic sporotrichosis in Brazil.

Author summary

Sporotrichosis is the leading subcutaneous mycosis worldwide. In the last decades, Brazil has faced an epidemic of zoonotic cases. The Brazilian Amazon region had no human cases reported in 2020, nevertheless, a striking rise in both human and animal cases was observed from 2020 to 2023, totalizing 950 human and 2,823 animal sporotrichosis. The majority of cases were reported in Manaus, the largest city in the Amazon, but cases were also documented in other populous municipalities. The study emphasizes the correlation between animal and human cases, as well as the spatial and temporal progression of the disease, moving from downtown areas to the periphery. Cats were identified as the primary reservoirs, with contact with infected animals being a significant risk factor for transmission. Urban areas, particularly domestic environments, were identified as common sites of infection. The predominant species identified was Sporothrix brasiliensis, which exhibits distinct characteristics favoring zoonotic transmission. This study emphasizes the urgent need for collaborative efforts among healthcare professionals, veterinarians, and public health authorities to implement effective control measures and mitigate the impact of the epidemic sporotrichosis in Brazil.

Introduction

Sporotrichosis, the most common human subcutaneous fungal infection worldwide, is a neglected disease caused by various fungi of the genus Sporothrix. It primarily affects the skin and subcutis but can also involve the lymph nodes, bones, joints, and internal organs in rare cases, especially among immunosuppressed [1,2].

Sporothrix spp. (1) are thermal dimorphic fungi belonging to the family Ophiostomataceae. The most common etiological agent of sporotrichosis is Sporothrix schenckii, although other species, such as Sporothrix brasiliensis, Sporothrix globosa, and Sporothrix mexicana, have also been implicated in human infections [3,4].

Human sporotrichosis occurs in many parts of the world, with higher incidence rates reported in tropical and subtropical regions, including Latin America, Asia, and Africa. The disease typically affects individuals engaged in outdoor activities or occupations involving contact with soil, plants, or organic matter, such as agriculture, gardening, forestry, and floristry. Although commonly associated with traumatic inoculation from plant material (classic transmission), sporotrichosis can also be acquired through inhalation of conidia or via direct inoculation during contact with infected animals (zoonotic transmission) [1,5,6].

Brazil has been facing an epidemic of sporotrichosis in the last two decades, characterized by a dramatic increase in human, canine, and feline cases attributed to zoonotic transmission, especially in the metropolitan regions from the Southern and the South regions [1,7]. The epidemic has raised awareness among healthcare professionals, veterinarians, and public health authorities about the need for enhanced surveillance, diagnosis, and management of sporotrichosis [8,9].

Although human sporotrichosis has been reported in the states from Amazon, they were usually associated with classic transmission [10]. This article reports the rising incidence of zoonotic sporotrichosis in the Amazon State, Brazil.

Methods

Ethics statement

Ethical approval for this study was obtained from the Fundação Alfredo da Matta Ethics Committee (approval number 6.053.509).

An ecologic study was performed by assessing the official registers of human and animal sporotrichosis diagnosed in the state of Amazon from 2020 to 2023. In the state of Amazon, both human and animal sporotrichosis are mandatory reporting. For the official registry, the diagnosis of sporotrichosis is based on clinical and epidemiological aspects and/or laboratory findings.

Demographic data, habits, clinical, and fungal identification were examined from the human cases. Geographic data from human and animal cases were recorded. Both demographic and geographic information were collected from online Brazilian databases “Sistema de Informação de Agravos de Notificação” (SINAN) and “Fundação de Vigilância em Saúde do Amazonas” (FVS).

Cultures were performed by sowing clinical specimens from the active lesion (exudate and/or biopsy fragment) in test tubes containing Sabouraud agar with chloramphenicol and Mycosel agar. Culture plates were incubated at room temperature for 6 to 10 days. After satisfactory growth of the filamentous colony, morphological analysis was carried out to confirm the genus Sporothrix.

For Sporothrix speciation, real-time polymerase chain reaction technique (qPCR) was used. First, Sporothrix spp genomic DNA was extracted from the clinical specimen using a Qiagen Blood & Tissue purification kit; purified DNA was quantified and stored in a -20°C freezer for later use in qPCR. For the detection and identification of species of Sporothrix (S.brasilensis, S. schenckii and S. globosa), TaqMan MGB-NFQ primers and probes were used. The following primers were used: CGTCTGAGCGTCTACTTCAACG and GGACGGCATCCATGGTACC. The probes used were CGATCGGCTTTGCTTTGGCCCTAGT (S.brasilensis), TCCCACCGTTTGGCAC (S. schenckii) and CGTCACAGTTTTGGCACGATTCTAACAATTTTT (S. globosa).

Data were summarized according to the municipality of the origin, geolocalization of the cases, age, gender, occupation, contact with an infected animal, and topography of the lesions.

Results

The annual records of 950 human cases and 2,823 animal cases of sporotrichosis from 2020 to 2023 are presented in Fig 1. The rise in human cases from 2021 to 2022 amounted to 304%, and from 2022 to 2023, it reached 249%. In comparison, the increase in animal cases was 428% and 345%, respectively, for the same periods (Fig 1).

Fig 1. Graphic curve representation of the exponential number of sporotrichosis cases in animals and humans, in Amazon State, Brazil, from 2021 to 2023 (Source: SINAN-NET).

Fig 1

Most of cases were from Manaus (96,9%) but also from other populous municipalities as Presidente Figueiredo (0,9%), Barcelos (0,8%), Iranduba (0,6%), Urucurituba (0,2%), Carauari (0,1%), Canutama (0,1%), Careiro da Várzea (0,1%), and Careiro (0,1%) (Fig 2).

Fig 2. Municipalities from the Brazilian Amazon Region with reported human sporotrichosis from 2021 to 2023 (Source: SINAN—NET) (Source of the basemap shapefile: IBGE https://www.ibge.gov.br/geociencias/organizacao-do-territorio/malhas-territoriais/15774-malhas.html).

Fig 2

Of the animals registered with sporotrichosis, 99.1% were cats (Fig 3).

Fig 3. Sporotrichosis in a cat from Manaus presenting with extensive facial ulceration involving the ears.

Fig 3

Note the emaciated appearance of the animal.

Among the human cases, 60.9% were females, with a mean (SD) age of 38.9 (18.9) years. Most of the individuals were self-declared as brown (81.5%). Adults (19–59 y.o.) were the most affected group, accounting for 68.5% of the cases, followed by the elderly (>60 y.o.) with 15.4%, children (0–12 y.o.) with 8.8%, and teenagers (13–18 y.o.) with 7.3% of the cases. None of the individuals affected were engaged in occupations involving plant work, agriculture, gardening, or soil-related activities.

Regarding the most affected site, it was observed that the upper limbs (39.6%), followed by the hands (29.6%), lower limbs (26.3%), chest (4.8%), feet (3.7%), head (3.2%), and abdomen (1.8%) were reported (Fig 4).

Fig 4. Human sporotrichosis.

Fig 4

A. Lymphocutaneous sporotrichosis. Ulcer with infiltrate borders on the thumb (local of inoculation–cat bite), followed by ascending (lymphangitic) erythematous nodules. B. Leg ulcer in an adult who refers a previous scratch from an infected cat.

Of cases where cutaneous lesions were described, 412 patients presented with ulcers, 82 with nodules, and 76 with papules.

The cases reported contact with infected animals in 77.7% of instances, with cats being the most commonly cited animals (73.5%), followed by dogs (2.7%), or both (1.0%).

Regarding possible infection sites, the urban area is noteworthy with 93.8% cases, and the home environment was the most common with 79.8% cases, followed by work with 4.4% and leisure places with 1.8% cases.

Only 66.7% of the individuals diagnosed with sporotrichosis collected samples for the mycologic exam. Of 78 cultures positive for Sporothrix spp, 65.4% were identified as S. brasiliensis.

All cases were treated with approved systemic antifungals for sporotrichosis therapy. Itraconazole is also the drug of choice for the treatment of infected cats. To date, no human death due to sporotrichosis has been registered in the state of Amazonas.

Up to May/2024, 428 confirmed cases of human and 704 animal cases of sporotrichosis were reported in the state of Amazonas.

Discussion

Since the initial reports of zoonotic sporotrichosis from São Paulo and Rio de Janeiro in the late 1990s, numerous municipalities in the Southern and South regions, such as Belo Horizonte, Curitiba, and Porto Alegre, have documented escalating series of urban transmission associated with infected felines. More recently, a series of zoonotic sporotrichosis were reported in Brasília (Central-West Region), as well as in municipalities across the Northeast Region, including Natal, Salvador, and Recife. These findings illustrate the progressive spread of the epidemic throughout major Brazilian metropolises [1115].

Manaus, with a population exceeding 2 million inhabitants, stands as the largest city in the Amazon region, serving as a pivotal communication hub connecting Brazil’s North Region with neighboring countries such as Peru, Colombia, Venezuela, and various Caribbean nations. The rising incidence of zoonotic sporotrichosis in Manaus mirrors the epidemic trajectory witnessed in other densely populated metropolises.

The Amazon, known for its vast rainforests and biodiversity, has experienced significant urbanization over the past few decades. This urban growth is driven by various factors, including economic development, rural-to-urban migration, infrastructure projects, and government policies. Despite the opportunities offered by urbanization, it also brings challenges such as environmental degradation, pressure on natural resources, social inequalities, and inadequate urban infrastructure. The unplanned expansion of cities and towns can lead to deforestation, habitat loss, pollution, and increased vulnerability to natural disasters and disease outbreaks [1619]. The presence of large colonies of feral cats in urban and peri-urban areas has facilitated the dissemination of Sporothrix species, contributing to the epidemic spread of sporotrichosis among humans and animals.

Zoonotic transmission is most commonly associated with dogs and cats, particularly domestic cats, which serve as the primary reservoirs for the fungus. Cytologic exams and cultures taken from skin lesions, nasal cavities, oral cavities, and nails of domestic cats frequently yield positive results, supporting the hypothesis of transmission through scratches or bites inflicted by infected animals. Additionally, contact with secretions containing infectious microorganisms further contributes to the spread of the disease [20].

Cat-transmitted sporotrichosis caused by S. brasiliensis has become a major public health concern and presents a distinct divergence from the traditional epidemiology of sporotrichosis [21]. As the presence of infected felines in densely populated urban areas precedes human infection, our data warns of an exponential rise in new cases of human and animal sporotrichosis in the Amazon region.

The pathogenic Sporothrix species share certain morphological characteristics but also exhibit differences that are important for the accurate understanding of their epidemiology and pathogenicity. Regarding their geographic distribution and ecological niches, S. brasiliensis is predominantly found in tropical and subtropical regions of South America, particularly in Brazil, where it is considered the main causative agent of the ongoing epidemic of sporotrichosis. On the other hand, S. globosa is more commonly associated with sporotrichosis in Asia. Genetic diversity and antifungal susceptibility also differ among the species. The cultures of S. brasiliensis exhibit slower growth compared to other species at 20°C (soil temperature), but they grow more rapidly than others at >36°C (mammalian tissue temperature), thereby favoring zoonotic transmission [4]. Concerning their virulence S. brasiliensis has been found to exhibit increased virulence compared to other species, leading to more severe clinical manifestations in infected individuals [22].

The upper extremities were the most frequently affected body site in the present study (69%), followed by the lower extremities (30%). Moreover, infection in urban areas (94%), contact with infected cats (78%), and the high identification of S. brasiliensis among positive cultures reinforce the expected pattern in a zoonotic epidemic, as observed in other Brazilian metropolises [15].

The epidemic of sporotrichosis in Brazil highlights the complex interplay between humans, animals, and the environment in the epidemiology of zoonotic fungal infections. Enhanced surveillance, diagnosis, and management of sporotrichosis are imperative to control the spread of the disease and minimize its impact on public health [21]. Nevertheless, as clinical manifestations in humans can vary from typically localized ulcers on the extremities to atypical immunoreactive forms, direct microscopic examination, and histopathology are insufficient for diagnosis, primary care services lack access to fungal culture, making a prompt diagnosis of sporotrichosis challenging in the public health system.

In conclusion, there has been an escalating incidence of animal and human sporotrichosis in the Brazilian Amazon state in the last four years, whose prevalent agent was S. brasiliensis. Collaborative efforts among healthcare professionals, veterinarians, and public health authorities are essential to implement effective control measures, educate at-risk populations, and promote responsible guidance for pet guardians to mitigate the burden of epidemic sporotrichosis in Brazil.

Data Availability

Data is available from public records at Fundação de Vigilância em Saúde do Amazonas homepage (https://www.fvs.am.gov.br).

Funding Statement

This study was supported by FAPEAM (Fundação de Amparo à Pesquisa do Estado do Amazonas, Brazil) through “Programa de Apoio à Formação em Ciências Dermatológicas – PRODERM-RH (grant #010/2023). HAM is a PVN-II Research Fellow from FAPEAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Alvarez CM, Oliveira MME, Pires RH. Sporotrichosis: A Review of a Neglected Disease in the Last 50 Years in Brazil. Microorganisms. 2022;10. doi: 10.3390/microorganisms10112152 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Schechtman RC, Falcao EMM, Carard M, Garcia MSC, Mercado DS, Hay RJ. Sporotrichosis: hyperendemic by zoonotic transmission, with atypical presentations, hypersensitivity reactions and greater severity. An Bras Dermatol. 2022;97:1–13. doi: 10.1016/j.abd.2021.07.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Rodrigues AM, Della Terra PP, Gremiao ID, Pereira SA, Orofino-Costa R, de Camargo ZP. The threat of emerging and re-emerging pathogenic Sporothrix species. Mycopathologia. 2020;185:813–842. doi: 10.1007/s11046-020-00425-0 [DOI] [PubMed] [Google Scholar]
  • 4.Marimon R, Cano J, Gene J, Sutton DA, Kawasaki M, Guarro J. Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest. J Clin Microbiol. 2007;45:3198–3206. doi: 10.1128/JCM.00808-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Haddad VJ, Miot HA, Bartoli LD, Cardoso Ade C, de Camargo RM. Localized lymphatic sporotrichosis after fish-induced injury (Tilapia sp.). Med Mycol. 2002;40:425–427. doi: 10.1080/mmy.40.4.425.427 [DOI] [PubMed] [Google Scholar]
  • 6.Marques GF, Martins AL, Sousa JM, Brandao LS, Wachholz PA, Masuda PY. Characterization of sporotrichosis cases treated in a dermatologic teaching unit in the state of Sao Paulo—Brazil, 2003–2013. An Bras Dermatol. 2015;90:273–275. doi: 10.1590/abd1806-4841.20153447 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Schechtman RC. Sporotrichosis: Part I. Skinmed. 2010;8:216–220; quiz 221. [PubMed] [Google Scholar]
  • 8.Sanchotene KO, Madrid IM, Klafke GB, Bergamashi M, Della Terra PP, Rodrigues AM, de Camargo ZP, Xavier MO. Sporothrix brasiliensis outbreaks and the rapid emergence of feline sporotrichosis. Mycoses. 2015;58:652–658. doi: 10.1111/myc.12414 [DOI] [PubMed] [Google Scholar]
  • 9.Orofino-Costa R, Freitas DFS, Bernardes-Engemann AR, Rodrigues AM, Talhari C, Ferraz CE, Veasey JV, Quintella L, Sousa M, Vettorato R, et al. Human sporotrichosis: recommendations from the Brazilian Society of Dermatology for the clinical, diagnostic and therapeutic management. An Bras Dermatol. 2022;97:757–777. doi: 10.1016/j.abd.2022.07.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Barros MB, Schubach AO, Schubach TM, Wanke B, Lambert-Passos SR. An epidemic of sporotrichosis in Rio de Janeiro, Brazil: epidemiological aspects of a series of cases. Epidemiol Infect. 2008;136:1192–1196. doi: 10.1017/S0950268807009727 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.de Oliveira Bento A, de Sena Costa AS, Lima SL, do Monte Alves M, de Azevedo Melo AS, Rodrigues AM, da Silva-Rocha WP, Milan EP, Chaves GM. The spread of cat-transmitted sporotrichosis due to Sporothrix brasiliensis in Brazil towards the Northeast region. PLoS Negl Trop Dis. 2021;15:e0009693. doi: 10.1371/journal.pntd.0009693 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Gremiao ID, Miranda LH, Reis EG, Rodrigues AM, Pereira SA. Zoonotic Epidemic of Sporotrichosis: Cat to Human Transmission. PLoS Pathog. 2017;13:e1006077. doi: 10.1371/journal.ppat.1006077 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Eudes Filho J, Santos IBD, Reis CMS, Patane JSL, Paredes V, Bernardes J, Poggiani S, Castro TCB, Gomez OM, Pereira SA, et al. A novel Sporothrix brasiliensis genomic variant in Midwestern Brazil: evidence for an older and wider sporotrichosis epidemic. Emerg Microbes Infect. 2020;9:2515–2525. doi: 10.1080/22221751.2020.1847001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Cognialli RCR, Caceres DH, Bastos F, Cavassin FB, Lustosa BPR, Vicente VA, Breda GL, Santos-Weiss I, Queiroz-Telles F. Rising Incidence of Sporothrix brasiliensis Infections, Curitiba, Brazil, 2011–2022. Emerg Infect Dis. 2023;29:1330–1339. doi: 10.3201/eid2907.230155 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Rodrigues AM, Goncalves SS, de Carvalho JA, Borba-Santos LP, Rozental S, Camargo ZP. Current Progress on Epidemiology, Diagnosis, and Treatment of Sporotrichosis and Their Future Trends. J Fungi (Basel). 2022;8. doi: 10.3390/jof8080776 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Junior VH, Mendes AL, Talhari CC, Miot HA. Impact of environmental changes on Dermatology. An Bras Dermatol. 2021;96:210–223. doi: 10.1016/j.abd.2020.11.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Richards P, VanWey L. Where Deforestation Leads to Urbanization: How Resource Extraction is Leading to Urban Growth in the Brazilian Amazon. Ann Assoc Am Geogr. 2015;105:806–823. doi: 10.1080/00045608.2015.1052337 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Chaves WA, Valle D, Tavares AS, Morcatty TQ, Wilcove DS. Impacts of rural to urban migration, urbanization, and generational change on consumption of wild animals in the Amazon. Conserv Biol. 2021;35:1186–1197. doi: 10.1111/cobi.13663 [DOI] [PubMed] [Google Scholar]
  • 19.Brilhante AF, Zampieri RA, Souza EA, Carneiro ACG, Barroso EP, Avila MM, Melchior LAK, Souza JL, Oliveira ES, Pinto MCG, et al. Preliminary observations of the urbanization and domiciliation of the American cutaneous leishmaniasis in Rio Branco, Acre, Western Amazon. Rev Soc Bras Med Trop. 2022;55. doi: 10.1590/0037-8682-0359-2022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Barros MB, de Almeida Paes R, Schubach AO. Sporothrix schenckii and Sporotrichosis. Clin Microbiol Rev. 2011;24:633–654. doi: 10.1128/CMR.00007-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Rossow JA, Queiroz-Telles F, Caceres DH, Beer KD, Jackson BR, Pereira JG, Ferreira Gremiao ID, Pereira SA. A One Health Approach to Combatting Sporothrix brasiliensis: Narrative Review of an Emerging Zoonotic Fungal Pathogen in South America. J Fungi (Basel). 2020;6. doi: 10.3390/jof6040247 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Della Terra PP, Rodrigues AM, Fernandes GF, Nishikaku AS, Burger E, de Camargo ZP. Exploring virulence and immunogenicity in the emerging pathogen Sporothrix brasiliensis. PLoS Negl Trop Dis. 2017;11:e0005903. doi: 10.1371/journal.pntd.0005903 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0012328.r001

Decision Letter 0

Joshua Nosanchuk

10 May 2024

Dear Dr. Talhari,

Thank you very much for submitting your manuscript "Zoonotic Sporotrichosis Outbreak: Emerging Public Health Threat in the Brazilian Amazon." for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Joshua Nosanchuk, MD

Section Editor

PLOS Neglected Tropical Diseases

Joshua Nosanchuk

Section Editor

PLOS Neglected Tropical Diseases

***********************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: The methods were clearly defined. The study design is adequated and address the objectives of the study. The statiscal analysis udes was adequated.

Reviewer #2: See Editorial and data presentation modifications

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: The results were clearly presented including some nice figures. Please, insert a graphic curve representation of the exponetial number of the cases during the period of the study.

Reviewer #2: See Editorial and data presentation modifications

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: The authors discussed the data very clearly, annd the public health was addressed very well.

Reviewer #2: See Editorial and data presentation modifications

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: Please, insert a graphic curve representation of the exponetial number of the cases during the period of the study.

Reviewer #2: Please consider the following suggestions as a contribution to improve the article for the journal readers.

1. Although the title suggests that authors will show data from the Braziliian Amazon region, in Methods it seems that data came only from Amazon state. Is that true?

2. Authors should change animal owners and ownership for guardians since nobody is the owner of other living being.

3. Figure 1 in Introduction is out of purpose and unnecessary. It should be withdrawn.

4. I did not see a statement about Ethics Committee. Could you please provide it?

5. Methods: “An ecologic study was performed by assessing the official registers of human and animal sporotrichosis diagnosed in the state of Amazon from 2020 to 2023.” Could you please provide which official registers and if it is available for everyone? Were they state or federal? SINAM? GAL? For more reliable data please specify better in the text.

6. Methods: “In the state of Amazon, both human and animal diseases are of mandatory

reporting.” The authors mean all human and animal disease or this is just for sporotrichosis? Since when has this been done? Do you think it is underreported? Are all demographic and clinical data reported in the official registers? Please, add a comment.

7. How were the diagnosis made? Was it an epidemiological inference?

There were 950 human cases diagnosed, but only 633 had culture made. Of these only 78 (12.3%) were positive for Sporothrix spp, and 65 out of 78 were identified as S. brasiliensis. Could you explain these data better? Which one was the species of these 13 Sporothrix not brasiliensis identified?

8. Statistical analysis were from the 950 patients?

9. Please standardize the binomial writing S. braSiliensis and not braZiliensis throughout the text.

10. Do official records report treatment outcome? Authors reported all cases were cured.

11. There was no hospitalization in these 950 patients? Anyone immunosupressed?

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: No more comments.

Reviewer #2: To the Authors

This is an important and well-written article with a special epidemiological interest about the spread of zoonotic sporotrichosis to Amazon in Brazil. However some issues should be regarded.

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Paulo Ricardo Criado

Reviewer #2: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

References

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article's retracted status in the References list and also include a citation and full reference for the retraction notice.

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0012328.r003

Decision Letter 1

Joshua Nosanchuk

27 Jun 2024

Dear Dr. Talhari,

We are pleased to inform you that your manuscript 'Zoonotic Sporotrichosis Outbreak: Emerging Public Health Threat in the Amazon State, Brazil.' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Joshua Nosanchuk, MD

Section Editor

PLOS Neglected Tropical Diseases

***********************************************************

Editorial note:  The authors are to be commended for their thoughtful and professional responses to the comments on the prior review.

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0012328.r004

Acceptance letter

Joshua Nosanchuk

15 Jul 2024

Dear Dr. Talhari,

We are delighted to inform you that your manuscript, "Zoonotic Sporotrichosis Outbreak: Emerging Public Health Threat in the Amazon State, Brazil.," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Letter to the Reviewers - PLOS 06.06.24.doc

    pntd.0012328.s001.doc (46.5KB, doc)

    Data Availability Statement

    Data is available from public records at Fundação de Vigilância em Saúde do Amazonas homepage (https://www.fvs.am.gov.br).


    Articles from PLOS Neglected Tropical Diseases are provided here courtesy of PLOS

    RESOURCES